Skip to contentHeffernan Michael Thomas — COLLINS INDUSTRIES INC insider: 221 transactions · InsiderLensHeffernan Michael Thomas
- Director at enGene Holdings Inc. · on record since Jul 10, 2025
- Director at CRITICAL THERAPEUTICS INC · on record since Dec 18, 2008
- Director at Federal Services Acquisition CORP · on record since Apr 18, 2012
- Director at Biohaven Ltd. · on record since Apr 30, 2026
- Director at ADVANCE TECHNOLOGIES INC · on record since Jun 4, 2026
- Director at Trevi Therapeutics, Inc. · on record since Jun 4, 2026
- Director at ADVANCED CELL TECHNOLOGY, INC. · on record since Jan 5, 2015
- Director at COLLINS INDUSTRIES INC · on record since May 18, 2015
- Chairman, President and CEO at COLLINS INDUSTRIES INC · on record since Jan 22, 2016
- Director at KERYX BIOPHARMACEUTICALS INC · on record since Jun 23, 2016
- Director at Akebia Therapeutics, Inc. · on record since Dec 13, 2018
- Director at Mirna Therapeutics, Inc. · on record since Dec 9, 2020
Insider trading activity of Heffernan Michael Thomas
- Transactions on record
- 221
- since Nov 4, 2008
- Open-market buys
- 1
- $25K
- Open-market sells
- 43
- $25.7M
- Companies traded
- 11
- last filing Jun 17, 2026
Figures computed from official regulatory filings — methodology.
Companies where Heffernan Michael Thomas has traded
- enGene Holdings Inc.2 tx · Jun 17, 2026
- Trevi Therapeutics, Inc.11 tx · $25K · Jun 4, 2026
- ADVANCE TECHNOLOGIES INC3 tx · Jun 4, 2026
- Biohaven Ltd.27 tx · $186.8K · Apr 30, 2026
- COLLINS INDUSTRIES INC110 tx · $32.9M · Feb 12, 2025
- Mirna Therapeutics, Inc.4 tx · Jun 26, 2023
- Akebia Therapeutics, Inc.11 tx · Jun 3, 2021
- KERYX BIOPHARMACEUTICALS INC7 tx · Dec 13, 2018
- ADVANCED CELL TECHNOLOGY, INC.15 tx · $263.5K · Feb 11, 2016
Track record of Heffernan Michael Thomas
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Heffernan Michael Thomas
Co-insiders of Heffernan Michael Thomas
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
17 tx · Oct 1, 2014
Anglade EddyADVANCED CELL TECHNOLOGY, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 17, 2026 | AwardD | 31,000 | 0.00 USD | — | SEC |
| Jun 4, 2026 | AwardD | 29,500 | 0.00 USD | $0 | SEC |
| Jun 4, 2026 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| Apr 30, 2026 | AwardD | 68,693 | 0.00 USD | $0 | SEC |
| Jul 10, 2025 | AwardD | 45,000 | 0.00 USD | $0 | SEC |
| Jun 18, 2025 | AwardD | 29,500 | 0.00 USD | $0 | SEC |
| Jun 13, 2025 | AwardD | 45,000 | 0.00 USD | $0 | SEC |
| May 7, 2025 | AwardD | 31,716 | 0.00 USD | $0 | SEC |
| Mar 26, 2025 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Feb 12, 2025 | Award | 4,820 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| May 16, 2024 | Award | 7,693 | 0.00 USD | $0 | SEC |
| May 2, 2024 | AwardD | 16,592 | 0.00 USD | $0 | SEC |
| Jun 30, 2023 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 26, 2023 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| May 19, 2023 | Award | 9,792 | 0.00 USD | $0 | SEC |
| May 4, 2023 | AwardD | 52,906 | 0.00 USD | $0 | SEC |
| Dec 27, 2022 | Sell | -4,989 | 23.00 USD | $114.7K | SEC |
| Dec 27, 2022 | ExerciseD | -3,820 | 0.00 USD | $0 | SEC |
| Dec 27, 2022 | ExerciseD | -4,989 | 0.00 USD | $0 | SEC |
| Dec 27, 2022 | Exercise | 3,820 | 16.15 USD | $61.7K | SEC |
| Dec 27, 2022 | ExerciseD | -15,995 | 0.00 USD | $0 | SEC |
| Dec 27, 2022 | Sell | -237 | 23.00 USD | $5.5K | SEC |
| Dec 27, 2022 | Exercise | 4,989 | 16.15 USD | $80.6K | SEC |
| Dec 27, 2022 | ExerciseD | -237 | 0.00 USD | $0 | SEC |